-
81
Transcription Factor E2F-1 Is Upregulated in Human Gastric Cancer Tissues and Its Overexpression Suppresses Gastric Tumor Cell Proliferation
Published 2007-01-01“…These findings suggest that E2F-1, a stable and conservative gene during the oncogenesis and progression of stomach cancers, may potentially serve as a biomarker for clinical diagnosis of gastric carcinomas and as a target for the development of novel therapeutic interventions to treat this disease.…”
Get full text
Article -
82
Malvidin-3-galactoside from blueberry suppresses the growth and metastasis potential of hepatocellular carcinoma cell Huh-7 by regulating apoptosis and metastases pathways
Published 2020-06-01“…The compound is well-characterized by its anti-oncogenesis function in multiple organs including liver. …”
Get full text
Article -
83
V-ATPase in glioma stem cells: a novel metabolic vulnerability
Published 2025-01-01Get full text
Article -
84
Comprehensive computational analysis of differentially expressed miRNAs and their influence on transcriptomic signatures in prostate cancer
Published 2025-01-01“…These miRNAs influence key genes, including FOXO3, NFAT3, PTEN, RHOA, VEGFA, SMAD7, and CDK2, playing significant roles in both tumor suppression and oncogenesis. The analysis revealed a complex network of miRNA-mRNA interactions, comprising 1849 nodes and 3604 edges. …”
Get full text
Article -
85
E3 ubiquitin ligase SYVN1 as a promising therapeutic target for diverse human diseases
Published 2025-02-01“…Consequently, SYVN1 plays a crucial role in both normal human physiology and the pathogenesis of various diseases, such as oncogenesis, cardiovascular disorders, immune regulation, skeletal anomalies, and neurological diseases. …”
Get full text
Article -
86
Computer analysis of regulation of hepatocarcinoma marker genes hypermethylated by HCV proteins
Published 2023-01-01“…Epigenetic changes are known to play an important role in the molecular genetic mechanisms of virus-induced oncogenesis. Aber rant DNA methylation is a mediator of epigenetic changes that are closely associated with the HCC pathogenesis and considered a biomarker for its early diagnosis. …”
Get full text
Article -
87
Free radical processes in rat liver in experimental diabetes, malignant growth and their combination
Published 2022-06-01“…The data showed that diabetes mellitus changes the specificity of oncogenesis depending on the sex of the animals. Males with the growth of Guerin's carcinoma in presence of diabetes in conditions of inhibition of SOD activity and a decrease in the ratio of conjugated enzymes of the first line of antioxidant defense demonstrate an intensification of LPO accompanied by an increase in the non‑enzymatic unit of the antioxidant system, while there is no increase in LPO in females, and the indicators of antioxidant activity change to a lesser extent.…”
Get full text
Article -
88
The genetic duet of concurrent RASAL1 and PTEN alterations promotes cancer aggressiveness by cooperatively activating the PI3K–AKT pathway
Published 2025-01-01“…Thus, the unique concurrent RASAL1 and PTEN defects drive oncogenesis and cancer aggressiveness by cooperatively activating the PI3K–AKT pathway. …”
Get full text
Article -
89
Unveiling <i>DENND2D</i> as a Novel Prognostic Biomarker for Prostate Cancer Recurrence: From Gene to Prognosis
Published 2024-12-01“…Emerging evidence suggests a critical role for differentially expressed in normal and neoplastic cell (<i>DENN</i>) domain-containing genes in oncogenesis; however, their implications in prostate cancer and BCR risk remain underexplored. …”
Get full text
Article -
90
Altered Atlas of Exercise-Responsive MicroRNAs Revealing miR-29a-3p Attacks Armored and Cold Tumors and Boosts Anti-B7-H3 Therapy
Published 2025-01-01“…Increasing evidence has shown that physical exercise remarkably inhibits oncogenesis and progression of numerous cancers and exercise-responsive microRNAs (miRNAs) exert a marked role in exercise-mediated tumor suppression. …”
Get full text
Article -
91
Unveiling the role of ASPP1 in cancer progression: pan-cancer bioinformatics and experimental validation in colorectal cancer
Published 2025-01-01“…Its expression varies across cancer types, suggesting a potential role in oncogenesis.MethodsThis study investigates ASPP1’s role across various cancers using a comprehensive bioinformatics approach. …”
Get full text
Article -
92
A KSHV RNA-binding protein promotes FOS to inhibit nuclease AEN and transactivate RGS2 for AKT phosphorylation
Published 2025-01-01“…Thus, KSHV lytic infection controls the expression of a subset of genes for signaling, cell cycle progression, and proliferation to potentially contribute to viral oncogenesis.…”
Get full text
Article -
93
Wnt signaling inhibits casein kinase 1α activity by modulating its interaction with protein phosphatase 2A
Published 2025-02-01Get full text
Article -
94
Investigation of metabolic features of glioblastoma tissue and the peritumoral environment using targeted metabolomics screening by LC-MS/MS and gene network analysis
Published 2025-01-01“…Analysis of the overrepresentation of Gene Ontology biological processes revealed the statistical significance of 184 processes, including apoptosis, the NF-kB signaling pathway, proliferation, migration, angiogenesis, and pyroptosis, many of which play an important role in oncogenesis. The findings of this study emphasize the pivotal role of sphingolipid metabolism in glioblastoma development and open new prospects for therapeutic approaches modulating this metabolism.…”
Get full text
Article -
95
A pan-cancer analysis of homeobox family: expression characteristics and latent significance in prognosis and immune microenvironment
Published 2025-02-01“…BackgroundThe Homeobox (HOX) gene family are conserved transcription factors that are essential for embryonic development, oncogenesis, and cancer suppression in biological beings. …”
Get full text
Article -
96
PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands
Published 2025-01-01“…Conclusion Taken together, our study underscores the role of PRMT5 in ACC oncogenesis and provides a strong rationale for the clinical development of PRMT5 inhibitors as a targeted monotherapy or combination therapy for treatment of patients with this rare disease, based on the analysis of their underlying molecular profile.…”
Get full text
Article -
97